IWC
RYTM icon

Integrated Wealth Concepts’s Rhythm Pharmaceuticals RYTM Stock Holding History

Integrated Wealth Concepts’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Buy
2,481
+1
+0% +$90 ﹤0.01% 2030
2026
Q1 		$216K Buy
+2,480
New +$241K ﹤0.01% 2067
2025
Q4 		– Sell
-2,491
Closed -$252K – 1972
2025
Q3 		$252K Buy
+2,491
New +$231K ﹤0.01% 1734

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Integrated Wealth Concepts's RYTM Position: Q2 2026 in Review

Integrated Wealth Concepts increased its Rhythm Pharmaceuticals (RYTM) stake by 0.04% in Q2 2026, buying an estimated $90 and bringing the position to 2,481 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

Integrated Wealth Concepts first reported a position in RYTM in Q3 2025 and has held it in 3 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Integrated Wealth Concepts held 2,481 shares of Rhythm Pharmaceuticals worth $275K as of Q2 2026.
  • Integrated Wealth Concepts bought 1 Rhythm Pharmaceuticals share in Q2 2026, an estimated $90.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #2030 holding.
  • Integrated Wealth Concepts first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.